Champlain Investment Partners LLC boosted its stake in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) by 0.3% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 10,862,083 shares of the company's stock after purchasing an additional 27,329 shares during the period. Confluent makes up approximately 1.8% of Champlain Investment Partners LLC's portfolio, making the stock its 4th biggest holding. Champlain Investment Partners LLC owned 3.19% of Confluent worth $254,607,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cloud Capital Management LLC acquired a new stake in Confluent during the 1st quarter worth about $26,000. Versant Capital Management Inc grew its position in shares of Confluent by 2,458.2% during the 1st quarter. Versant Capital Management Inc now owns 1,714 shares of the company's stock valued at $40,000 after acquiring an additional 1,647 shares during the period. SVB Wealth LLC acquired a new stake in shares of Confluent during the 1st quarter valued at about $54,000. GAMMA Investing LLC grew its position in shares of Confluent by 26.8% during the 1st quarter. GAMMA Investing LLC now owns 3,128 shares of the company's stock valued at $73,000 after acquiring an additional 661 shares during the period. Finally, PNC Financial Services Group Inc. grew its position in shares of Confluent by 39.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 4,053 shares of the company's stock valued at $95,000 after acquiring an additional 1,143 shares during the period. 78.09% of the stock is owned by institutional investors and hedge funds.
Confluent Price Performance
Confluent stock traded down $0.19 during midday trading on Monday, reaching $19.86. The company had a trading volume of 5,984,950 shares, compared to its average volume of 9,494,722. The company has a market capitalization of $6.85 billion, a P/E ratio of -21.13 and a beta of 0.97. Confluent, Inc. has a 12-month low of $15.64 and a 12-month high of $37.90. The firm's fifty day simple moving average is $21.95 and its 200-day simple moving average is $23.63. The company has a debt-to-equity ratio of 1.03, a current ratio of 3.98 and a quick ratio of 3.98.
Confluent (NASDAQ:CFLT - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.08 by $0.01. The firm had revenue of $282.29 million for the quarter, compared to analyst estimates of $278.32 million. Confluent had a negative net margin of 29.27% and a negative return on equity of 27.34%. Confluent's quarterly revenue was up 20.1% compared to the same quarter last year. During the same period last year, the company posted $0.06 EPS. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. As a group, equities analysts anticipate that Confluent, Inc. will post -0.83 EPS for the current year.
Insiders Place Their Bets
In other Confluent news, CRO Ban Ryan Norris Mac sold 15,200 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $17.01, for a total value of $258,552.00. Following the transaction, the executive directly owned 397,345 shares of the company's stock, valued at $6,758,838.45. This trade represents a 3.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Rohan Sivaram sold 26,097 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $17.01, for a total transaction of $443,909.97. Following the completion of the transaction, the chief financial officer directly owned 636,596 shares in the company, valued at $10,828,497.96. This trade represents a 3.94% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 599,117 shares of company stock worth $12,377,994. 13.82% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on the company. Citigroup dropped their target price on Confluent from $30.00 to $20.00 and set a "neutral" rating on the stock in a research report on Monday, August 4th. Needham & Company LLC dropped their target price on Confluent from $26.00 to $24.00 and set a "buy" rating on the stock in a research report on Thursday, July 31st. UBS Group dropped their target price on Confluent from $32.00 to $28.00 and set a "buy" rating on the stock in a research report on Thursday, July 31st. Piper Sandler dropped their target price on Confluent from $32.00 to $27.00 and set an "overweight" rating on the stock in a research report on Thursday, July 31st. Finally, Guggenheim dropped their target price on Confluent from $31.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday, July 31st. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Confluent currently has an average rating of "Moderate Buy" and a consensus price target of $27.36.
Get Our Latest Research Report on Confluent
Confluent Profile
(
Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Further Reading

Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.